How times a day do you take this medicine?

Here is the some steps to help you to save money on Imatinib purchase.

Read drug prescription


Imatinib uses

is a protein-tyrosine kinase inhibitor, prescribed for treating certain type of cancers such as chronic myelogenous leukemia (cancer of the white blood cells, a

Imatinib indications

Imatinib is a protein-tyrosine kinase inhibitor, prescribed for treating certain type of cancers such as chronic myelogenous leukemia (cancer of the white blood cells, acute lymphoblastic leukemia(cancer of the white blood cells), gastrointestinal stromal tumors (tumors of the gastrointestinal tract and other cancers. It prevents the growth of cancer cells.  

Imatinib dosage

PO- Dose varies from 400mg/day to 800mg/day depending on condition. 400 to 600mg/day should be administered once daily, 800mg/day, should be administered twice daily.

Imatinib usage

Available in the form tablets, to take by mouth (orally) with a meal and glass of water (8 oz/240 ml).

Imatinib precautions

Caution should be exercised in patients with history of high blood pressure, heart attack, irregular heartbeat, diabetes, heart, lung, thyroid or liver disease, smokers, street drug and heavy alcohol users.
Avoid excess dosage.
It may cause diarrhea during the treatment. Consult with your doctor if it does so.
Consult with your doctor during pregnancy and breastfeeding.

Imatinib side effects

Heart- Compression of the heart, inflammation of the pericardium and blood clot.
Central nervous System- Loss of strength, fatigue/lethargy, flu like symptoms, headache, dizziness, depression, sleeplessness, anxiety, decreased tactile sensibility, tingling, weakness, CNS hemorrhage and swelling of the brain.
Skin- Rash/desquamation, itching, baldness, sweating, dry skin, redness of the skin and flushing.
Eye and ENT- Eye edema, inflammation of the nose and pharynx, increased tears, pharynx and the esophagus pain, runny nose, blurred vision, bleeding in conjunctiva, dry eye and eyelid swelling.
Gastrointestinal- Nausea, dry mouth, gastritis, loss of appetite, difficulty in swallowing, gastro esophageal reflux, GI bleeding, gas, intestinal obstruction, diarrhea, vomiting, abdominal pain, constipation, flatulence, abdominal distention and tumor hemorrhage/tumor necrosis.
Blood-Bleeding, decrease in white blood cells, platelets, hemoglobin, subdural hematoma (SDH).

Imatinib warning

Avoid excess dosage.
It may affect blood-clot, avoid unusual bruising or injury.

Imatinib storage conditions

Store at 25°C. Keep in airtight container. Keep away from children. ♦ Safety Labeling Changes Approved By FDA

Compare prices at online shops


StrengthQuantityPrice, USDCountry
400 mg90 $1.00Canada, Mauritius, Singapore, Turkey, UK, USA
100 mg10 $109.99Canada, Mauritius, Singapore, Turkey, UK, USA
100 mg30 $260.00Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
400 mg30 $329.00Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
100 mg90 $299.00Australia, Canada, NZ, Singapore, Turkey
400 mg90 $830.00Australia, Canada, NZ, Singapore, Turkey


Select the most affordable brand or generic drug


StrengthQuantityPrice, USDCountry
10 Tablets$13.30
Imalak 100 mg Tablet $1.33
Imatib 400mg Tablet $3.14Cipla Ltd
IMATIB film-coated tab 400 mg x 10's $39.44Cipla
IMATIB 400MG TABLET 1 strip(s) (10 tablets each) $42.00Cipla Ltd
IMATIB cap 100 mg x 10's $11.90Cipla
Imatib 100mg Capsule $1.31Cipla Ltd
IMATIB 100MG CAPSULE 1 strip(s) (10 capsules each) $13.13Cipla Ltd
100 mg10 Tablet$13.30
400 mg10 Tablet$42.00
400 mg x 10's $42.00
MESYLONIB film-coated tab 400 mg x 10's $42.00Miracalus
Mesylonib 400mg FC-TAB / 10 $42.00
100 mg x 10's $13.30
MESYLONIB film-coated tab 100 mg x 10's $13.30Miracalus
Mesylonib 100mg FC-TAB / 10 $13.30
100 mg10 Capsule$14.00
Zoleta 100 mg Capsule $1.40

References

  1. "Imatinib". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
  2. "Imatinib". http://www.drugbank.ca/drugs/DB0061... (accessed August 28, 2018).
  3. "Bkj8m8g5hi: the unique ingredient identifier (unii) is an alphanumeric substance identifier from the joint fda/usp substance registration system (srs).". https://www.fda.gov/ForIndustry/Dat... (accessed August 28, 2018).

Imatinib - Frequently asked Questions

Can Imatinib be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

Can Imatinib be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can Imatinib be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

Reviews

Following the study conducted by gmedication.com on Imatinib, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Imatinib. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.

Patient reports

Patient reported useful

No survey data has been collected yet


Patient reported side effects

No survey data has been collected yet


Patient reported price estimates

No survey data has been collected yet


Patient reported frequency of use

No survey data has been collected yet


Patient reported doses

No survey data has been collected yet


Patient reported time for results

No survey data has been collected yet


Patient reported administration

No survey data has been collected yet


Patient reported age

No survey data has been collected yet


Patient reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 1 here

The information was verified by Dr. Vishal Pawar, MD Pharmacology